{"schema_version":"1","generated_at":"2026-11-01T03:52:14.895Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ana-antun","json_url":"https://www.findmykol.com/kol/ana-antun/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ana-antun","name":"Ana Antun","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Emory University","institution_url":"https://www.findmykol.com/institution/emory-university","city":"Decatur","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1447437538","openalex":"A5069454266"},"summary":"Ana Antun is an Oncology physician affiliated with Emory University. OpenAlex indexes 61 publications with 814 citations (h-index 15); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":61,"cited_by_count":814,"h_index":15,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03086252","title":"Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study","phase":"NA","status":"WITHDRAWN","role":"Overall official","sponsor":"Emory University","source_url":"https://clinicaltrials.gov/study/NCT03086252","trial_url":"https://www.findmykol.com/trial/NCT03086252"},{"nct":"NCT02074436","title":"PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Emory University","source_url":"https://clinicaltrials.gov/study/NCT02074436","trial_url":"https://www.findmykol.com/trial/NCT02074436"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":2688,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447437538"},{"payer":"GENZYME CORPORATION","program_year":2024,"amount_usd":3062.84,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447437538"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2024,"amount_usd":100.91,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447437538"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1447437538","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Blood & clotting","share_pct":100,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Eliquis","share_pct":76.2},{"name":"Xarelto","share_pct":23.8}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Race, Ethnicity, and Hemophilia: A Scoping Review","year":2026,"journal":"Journal of Racial and Ethnic Health Disparities","source_url":"https://doi.org/10.1007/s40615-025-02758-2","status":"verified"},{"title":"Global patterns of hemophilia drug trials, hemophilia care, and health care measures","year":2025,"journal":"Research and Practice in Thrombosis and Haemostasis","source_url":"https://doi.org/10.1016/j.rpth.2025.102714","status":"verified"},{"title":"Fetal and maternal morbidity in pregnant patients with thrombotic thrombocytopenic purpura: A Nationwide analysis","year":2025,"journal":"Transfusion","source_url":"https://doi.org/10.1111/trf.18442","status":"verified"},{"title":"Maternal and fetal outcomes in immune-mediated thrombotic thrombocytopenic purpura: A scoping review","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-4891","status":"verified"},{"title":"Comparing the safety of direct oral anticoagulants vs. low-molecular-weight heparin in patients with thrombocytopenia and venous thromboembolism","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-3128","status":"verified"}],"source":"works"},"contact":{"address_1":"1670 CLAIRMONT RD","city":"Decatur","state":"GA","zip":"300334004","phone":"404-593-6732","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1447437538","source":"identity"},"similar":[{"name":"James Lah","slug":"james-lah","institution":"Emory University","specialty":"Neurology","url":"https://www.findmykol.com/kol/james-lah","json_url":"https://www.findmykol.com/kol/james-lah/profile.json"},{"name":"Keith Delman","slug":"keith-delman","institution":"Emory University","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/keith-delman","json_url":"https://www.findmykol.com/kol/keith-delman/profile.json"},{"name":"John Puskas","slug":"john-puskas","institution":"Emory University","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/john-puskas","json_url":"https://www.findmykol.com/kol/john-puskas/profile.json"},{"name":"Jack Arbiser","slug":"jack-arbiser","institution":"Emory University","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jack-arbiser","json_url":"https://www.findmykol.com/kol/jack-arbiser/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2010-07-14","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}